Search hospitals
>
Illinois
>
Chicago
University of Illinois at Chicago
Claim this profile
Chicago, Illinois 60612
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Sickle Cell Disease
Conducts research for Brain Tumor
906 reported clinical trials
63 medical researchers
Summary
University of Illinois at Chicago is a medical facility located in Chicago, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Sickle Cell Disease, Brain Tumor and other specialties. University of Illinois at Chicago is involved with conducting 906 clinical trials across 1,229 conditions. There are 63 research doctors associated with this hospital, such as Mary L. Schmidt, Lawrence E. Feldman, Peter Riedell, MD, and Shikha Jain.
Area of expertise
Cancer
University of Illinois at Chicago has run 88 trials for Cancer. Some of their research focus areas include:
Breast Cancer
University of Illinois at Chicago has run 68 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Mary L. Schmidt
University of Illinois
8 years of reported clinical research
Lawrence E. Feldman
University of Illinois
6 years of reported clinical research
Peter Riedell, MD
University of Chicago
8 years of reported clinical research
Shikha Jain
University of Illinois
7 years of reported clinical research
Clinical Trials running at University of Illinois at Chicago
Breast Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Breast cancer
Multiple Myeloma
Cancer
Kidney Cancer
Pancreatic Cancer
Esophageal cancer
Abemaciclib + Hormone Therapy
for Breast Cancer
This is a post-marketing single arm, phase IV trial in which patients with high-risk early-stage HR+HER2- breast cancer will receive adjuvant abemaciclib in combination with endocrine therapy (ET) After study intervention, participants will remain on combination abemaciclib + ET at the discretion of their treating providers
Recruiting
3 awards
Phase 4
5 criteria
PF-07220060 + Letrozole
for Breast Cancer
The purpose of this study is to determine the safety and efficacy of PF-07220060 with letrozole compared to approved treatments (ie, palbociclib, ribociclib or abemaciclib with letrozole) in people with breast cancer: * HR-positive (breast cancer cells that need estrogen or progesterone to grow) * HER2-negative (cells that have a small amount or none of a protein called HER2 on their surface); * locally advanced (that has spread from where it started to nearby tissue or lymph nodes) or metastatic disease (the spread of cancer to other places in the body) * who have not received any prior systemic anti-cancer treatment for advanced/metastatic disease. Approximately half of the participants will receive PF-07220060 plus letrozole while the other half of participants will receive the investigator's choice of treatment plus letrozole. The study team will monitor how each participant is doing with the study treatment during regular visits at the study clinic.
Recruiting
2 awards
Phase 3
4 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting
2 awards
Phase 3
6 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Illinois at Chicago?
University of Illinois at Chicago is a medical facility located in Chicago, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Sickle Cell Disease, Brain Tumor and other specialties. University of Illinois at Chicago is involved with conducting 906 clinical trials across 1,229 conditions. There are 63 research doctors associated with this hospital, such as Mary L. Schmidt, Lawrence E. Feldman, Peter Riedell, MD, and Shikha Jain.
Where is University of Illinois at Chicago located?
The University of Illinois Hospital is situated at 1740 W Taylor St, Chicago, IL 60612, within the Illinois Medical District. For those driving, access is via the I-90/I-94 W, exit 50A for Damen Ave, then a right onto Taylor St. Public transportation is available through the CTA Pink Line Polk Station, conveniently located within walking distance.
Who should I call to ask about financial aid or insurance network?
**University of Illinois at Chicago (UIC) Hospital Financial Assistance and Insurance Contacts** **Financial Assistance:** - **Phone:** 312.413.7621 - **Email:** getinsured@uic.edu - **Address:** Financial Counselor, University of Illinois Hospital & Health Sciences System, 1740 W. Taylor St., Chicago, IL 60612 - **Website:** [Financial Assistance Information](https://hospital.uillinois.edu/patients-and-visitors/patient-information/financial-assistance) **Insurance Inquiries:** - **Phone:** 312.413.7621 - **Website:** [Insurance Information](https://www.uic.edu/apps/departments-az/search?dispatch=find&orgid=99946) For details on financial assistance programs, insurance options, and the application process for financial aid, please contact the respective departments.
What insurance does University of Illinois at Chicago accept?
The University of Illinois at Chicago (UIC) accepts a wide range of insurance plans, including but not limited to Blue Cross Community MMAI, Campus Care, County Care, Harmony, Illinicare, Meridian, Molina, Next Level, and Blue Cross Community Family Health Plan (FHP). UI Health also participates in Medicare and various health plans such as Aetna, BCBSIL, Blue Advantage HMO, Blue Choice Opt PPO, Blue Choice PPO, Blue Choice Preferred PPO, Blue Cross Community Medicaid, and more. For international students, it's crucial to ensure that their health insurance coverage meets all J-1 Exchange Visitor requirements.
What awards or recognition has University of Illinois at Chicago received?
The University of Illinois Hospital & Health Sciences System, located in Chicago, Illinois, is renowned for its extensive research across multiple disciplines including alternative, complementary, and traditional medicine, biotechnology and biodefense, cancer biology, drug discovery, infectious diseases, neuroscience, and patient safety. It has garnered numerous research grants, with its researchers acclaimed globally. Furthermore, the University of Illinois at Chicago (UIC) annually hosts the Research and Scholarship Award competition, honoring significant contributions to research and scholarship at UIC.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.